Eu­ro­pean Com­mis­sion fi­nal­izes joint clin­i­cal as­sess­ment rules for mem­ber coun­tries

Last year
Pharma
Law

UK biotech re­vives for­mer Ky­owa Kirin can­cer drug for Ep­stein-Barr-dri­ven dis­eases

Last year
Startups
R&D

Cy­to­ki­net­ics CEO de­fends Roy­al­ty Phar­ma deal: 'That nar­ra­tive was hi­jacked'

Last year
Deals

Mer­ck KGaA avoids pros­e­cu­tion af­ter co­op­er­at­ing with DOJ to un­cov­er Chi­na ex­port scheme

Last year
China
Law

Bi­cy­cle’s $555M place­ment; Tan­go Ther­a­peu­tics scraps can­cer pro­gram

Last year
News Briefing

Ex­clu­sive: SR One rais­es $200M+ for third fund, still with GSK sup­port

Last year
Financing

Chi­nese CD­MO takes over Pfiz­er’s UK fa­cil­i­ty; Serum In­sti­tute ships malar­ia vac­cine to Africa

Last year
Manufacturing

At­ro­pos Health rais­es $33M to arm doc­tors and phar­ma com­pa­nies with ev­i­dence

Last year
Pharma
Health Tech

Ex­clu­sive: Se­nior pri­ma­ry care start­up Gath­er Health has raised $16M in a new round

Last year
Deals
Health Tech

Start­up launch­es with ‘RNA sen­sor’ tech­nol­o­gy from Stan­ford and MIT to bet­ter con­trol mR­NA ther­a­pies

Last year
Financing

As­traZeneca taps more Chi­na-de­rived tech with $19M can­cer deal for Nona an­ti­bod­ies

Last year
Deals
R&D

Re­NA­gade is ac­quired by RNA ri­val a year af­ter megaround-backed launch

Last year
Deals
Cell/Gene Tx

Grey Wolf reels in $50M to ex­pand in­to au­toim­mune dis­eases

Last year
Financing
Startups

Take­da en­ters hot mol­e­c­u­lar glue space in up to $1.2B pact with De­gron

Last year
Startups
China

Fed­er­al ap­peals court sides with drug­mak­ers on 340B lim­i­ta­tions

Last year
Pharma
Law

Mer­ck KGaA makes $600M bet to boost man­u­fac­tur­ing for vi­ral vec­tors

Last year
Deals
Cell/Gene Tx

FDA ques­tions hy­po­glycemia risk for No­vo Nordisk's once-week­ly in­sulin ahead of ad­comm

Last year
Pharma
FDA+

Pfiz­er an­nounces an­oth­er $1.5B in cost cuts — and plans for more to come

Last year
People
Pharma

AGC Bi­o­log­ics, Bio­Con­nec­tion forge part­ner­ship to be an al­ter­na­tive to WuXi

Last year
China
Manufacturing

House com­mit­tee press­es FDA cen­ter di­rec­tors on do­mes­tic man­u­fac­tur­ing, LDTs

Last year
Pharma
FDA+

FDA's Marks, Wood­cock talk reg­u­la­to­ry flex­i­bil­i­ty for new rare dis­ease drugs

Last year
Cell/Gene Tx
FDA+

Twin Health ex­pands in­to treat­ing obe­si­ty with dig­i­tal twins

Last year
Startups
Health Tech

Sum­it­o­mo and Japan Na­tion­al In­sti­tute's uni­ver­sal in­fluen­za vac­cine en­ters clin­i­cal tri­als

Last year
Nikkei Biotechnology

Cri­net­ic­s' stock jumps fol­low­ing promis­ing Ph2 da­ta in four pa­tients with rare ge­net­ic dis­or­der

Last year
R&D
First page Previous page 153154155156157158159 Next page Last page
A service from the Financial Times